background
immun
evas
one
recogn
hallmark
cancer
inflammatori
respons
cancer
also
contribut
directli
oncogenesi
sinc
immun
system
hardwir
protect
host
possibl
cancer
regardless
histolog
origin
endow
common
share
inflammatori
cancerassoci
molecular
pattern
icamp
promot
oncoinflamm
howev
definit
icamp
conceptu
experiment
investig
relationship
cancer
inflamm
observ
earli
th
centuri
ronald
virchow
describ
tumorinfiltr
leukocyt
howev
past
two
decad
inflammatori
microenviron
recogn
key
compon
carcinogenesi
involv
cancer
initi
promot
metastasi
chronic
infect
establish
etiolog
factor
mani
human
cancer
similarli
chronic
inflamm
inflammatori
bowel
diseas
chronic
hepat
increas
risk
colorect
hepatocellular
carcinoma
respect
case
immunesurveil
thought
elimin
tumorigen
foci
howev
canceriniti
cell
reprogram
immun
cell
creat
tumorfriendli
microenviron
therebi
evad
antitumor
immun
addit
cancer
educ
innat
adapt
arm
immun
system
myeloidderiv
suppressor
cell
regulatori
cell
mediat
promot
growth
invas
role
inflamm
carcinogenesi
begin
tumor
initi
multipl
mechan
genotox
stress
via
reactiv
oxygen
speci
induct
activationinduc
cytidin
deaminas
aid
tnfainduc
entri
bcatenin
nucleu
other
beyond
initi
cytokin
activ
protumorigen
transcript
factor
nfkb
exist
cancer
cell
inflammatori
cell
also
dampen
antitumor
immun
molecul
arginas
interfer
function
lymphocyt
epithelialmesenchym
transit
also
favor
cytokin
tgfb
promot
distal
metastasi
oncoinflamm
therefor
contribut
differ
cancer
hallmark
includ
cell
prolifer
angiogenesi
escap
apoptosi
howev
despit
elabor
crosstalk
cancer
cell
inflammatori
microenviron
approach
uncov
critic
player
interact
far
sporad
noncomprehens
studi
hypothes
common
inflammatori
pattern
exist
among
differ
cancer
type
constitut
signatur
profil
term
icamp
perform
comprehens
analysi
gene
express
across
common
epitheli
cancer
type
robust
oncoinflammatori
profil
identifi
demonstr
independ
strong
predict
valu
clinic
outcom
multipl
cancer
approach
also
led
discoveri
valid
singl
consist
upregul
protein
cancer
access
patient
sampl
anonym
analysi
data
approv
institut
review
board
human
research
medic
univers
south
carolina
analysi
includ
gene
express
profil
type
cancer
one
dataset
includ
cancer
type
result
total
dataset
cancer
includ
studi
breast
colon
lung
oral
prostat
pancreat
gastric
cancer
dataset
obtain
gene
express
omnibu
geo
dataset
ncbi
public
databas
dataset
includ
microarray
mrna
express
data
cancer
normal
tissu
tabl
dataset
use
affymetrix
human
genom
plu
array
platform
quantif
gene
express
level
seven
epitheli
cancer
type
investig
identifi
gene
show
consist
differenti
express
use
recent
develop
consist
differenti
express
pattern
cdep
method
raw
microarray
data
compar
gene
express
normal
cancer
cell
download
ncbi
geo
databas
http
wwwncbinlmnihgovgd
tabl
exclud
adenoma
sampl
colon
dataset
sampl
studi
cancer
tissu
normal
express
valu
replic
sampl
pancreat
cancer
dataset
averag
raw
dataset
preprocess
individu
dataset
gene
express
valu
adjust
normal
gcrma
approach
implement
r
fals
discoveri
rate
fdr
gene
normal
dataset
calcul
use
permut
method
implement
rankprod
packag
r
gene
dataset
associ
raw
fdr
f
gi
f
gi
updownregul
gene
present
platform
dataset
median
fdr
valu
dataset
assign
cdep
metaanalysi
appli
raw
fdr
seven
dataset
dataset
fals
posit
rate
defin
probabl
nonupregul
gene
fals
call
overexpress
nondownregul
gene
fals
call
repress
number
gene
upregul
downregul
nondifferenti
express
dataset
estim
beta
mixtur
model
implement
winbug
base
rate
use
independ
bernoulli
distribut
calcul
likelihood
gene
fals
identifi
overunderexpress
among
seven
dataset
fdr
threshold
l
procedur
evalu
estim
fals
discoveri
rate
fdr
g
observ
expect
log
likelihood
ie
proport
fals
posit
among
gene
identifi
consist
differenti
express
null
log
likelihood
comput
permut
f
gi
f
gi
valu
rel
gene
within
dataset
perform
procedur
calcul
expect
valu
null
log
likelihood
permut
b
everi
gene
use
fdr
cutoff
identifi
differenti
express
gene
across
cancer
type
set
upregul
downregul
gene
enter
david
databas
http
davidabccncifcrfgov
gene
annot
relat
inflamm
andor
immun
respons
select
analysi
six
seven
cancer
type
correspond
normal
tissu
investig
protein
express
level
immunerel
gene
hpat
wwwproteinatlasorg
oncomin
databas
wwwoncomineorg
use
identifi
clinic
signific
immunerel
gene
abil
predict
patient
surviv
diseas
recurr
xtile
softwar
use
determin
optim
cutoff
point
separ
low
risk
high
risk
patient
igi
ovarian
cancer
patient
summat
risk
valu
icamp
gene
independ
prognost
signific
demonstr
train
dataset
gene
ednrrb
lox
mal
mif
pigr
predict
valu
igi
test
use
independ
tcga
ovarian
cancer
dataset
base
cutoff
valu
predetermin
train
dataset
given
patient
valu
gene
confer
poor
prognosi
rel
risk
rr
wherea
valu
gene
whose
express
patient
predict
better
prognosi
set
zero
exampl
patient
fall
high
risk
group
gene
low
risk
group
gene
patient
igi
summat
rel
risk
gene
rel
risk
gene
sinc
valu
gene
zero
use
ingenu
pathway
analysi
tool
wwwingenu
com
inflammatori
gene
map
multipl
network
show
overexpress
underexpress
one
tissu
microarray
tma
colon
cancer
headneck
cancer
specimen
contain
formalinfix
paraffin
embed
tissu
colon
cancer
tma
develop
patient
specimen
obtain
medic
univers
south
carolina
musc
charleston
sc
usa
studi
approv
institut
review
board
colon
cancer
cohort
consist
tumor
patient
adjac
normal
tissu
along
lymph
node
metastat
sampl
normal
cancer
specimen
least
duplic
clinic
demograph
inform
includ
age
sex
histolog
type
grade
tumor
lymph
node
n
stage
overal
recurrencefre
surviv
obtain
cancer
registri
holl
cancer
center
medic
univers
south
carolina
headneck
cancer
tma
obtain
us
biomax
contain
headneck
squamou
cell
carcinoma
normal
specimen
independ
patient
section
cut
tma
block
stain
perform
use
rabbit
polyclon
antibodi
specif
human
abcam
cat
dilut
slide
bake
hour
deparaffin
antigen
retriev
use
citrat
buffer
ph
endogen
peroxidas
quench
use
h
dh
minut
nonspecif
bind
block
normal
goat
serum
hour
room
temperatur
sampl
incub
antibodi
hour
follow
secondari
antibodi
vectastain
abc
kit
develop
use
dab
substrat
vector
lab
stain
show
absolut
specif
nucleu
without
discern
offtarget
signal
quantif
perform
surgic
pathologist
ss
blind
patient
clinic
paramet
quantif
includ
nuclear
stain
intens
faint
datamin
workflow
identif
consist
differenti
express
gene
seven
human
cancer
type
raw
data
dataset
tabl
first
obtain
gene
express
omnibu
geo
dataset
correspond
one
cancer
type
breast
colon
lung
oral
pancreat
prostat
gastric
cancer
dataset
includ
express
microarray
profil
cancer
tissu
correspond
normal
tissu
determin
dysregul
gene
cancer
type
consist
differenti
express
pattern
cdep
methodolog
implement
identifi
differenti
express
gene
across
seven
dataset
gene
upregul
gene
downregul
use
david
gene
function
classifi
immunerel
gene
identifi
figur
tabl
improv
signaltonois
ratio
gene
show
fold
chang
fc
five
cancer
type
exclud
result
robust
inflammatori
profil
term
icamp
upregul
downregul
gene
mrna
level
figur
protein
express
icamp
verifi
ihc
cancer
type
breast
colon
lung
pancreat
prostat
gastric
mine
human
protein
atla
tabl
figur
clinic
signific
icamp
determin
use
oncomin
databas
final
ingenu
pathway
analysi
tool
use
pinpoint
function
icamp
cancerassoci
inflamm
among
upregul
gene
icamp
involv
posit
regul
lymphocyt
apoptosi
significantli
enrich
fold
small
chemokin
cxc
famili
enrich
fold
figur
addit
tumor
also
enrich
gene
immunolog
categori
hostviru
interact
respons
wound
figur
downregul
gene
highli
enrich
complement
compon
altern
pathway
fold
tcellassoci
gene
granzym
mal
cell
differenti
protein
fold
gene
involv
regul
nk
cell
function
lectinlik
receptor
subfamili
k
member
figur
function
mani
icamp
gene
yet
understood
exampl
shown
upregul
across
broadspectrum
cancer
type
figur
unclear
howev
possibl
tumorpromot
activ
due
function
nuclear
transport
select
immunoregulatori
protein
interferoncinduc
transcript
factor
examin
protein
express
pattern
icamp
gene
took
advantag
public
avail
protein
express
databas
hpat
gene
show
differenti
express
ihc
exclud
due
limit
sensit
method
use
ihc
filter
step
would
expand
fals
neg
observ
limit
power
studi
howev
inform
defin
gene
show
protein
chang
cancer
type
direct
implic
choic
gene
function
analys
exampl
found
increas
cancer
type
except
pancreat
cancer
figur
hand
polymer
immunoglobulin
receptor
pigr
protein
involv
transepitheli
transport
immunoglobulin
consist
downregul
cancer
cell
figur
altogeth
protein
express
data
avail
upregul
downregul
gene
total
gene
tabl
figur
upregul
gene
mrna
level
also
upregul
ihc
least
cancer
type
studi
transcript
downregul
gene
examin
protein
express
show
downregul
ihc
cancer
type
clinic
signific
icamp
gene
next
chose
use
ovarian
cancer
studi
signific
icamp
gene
base
two
consider
first
ovarian
malign
epitheli
origin
histolog
similar
seven
cancer
type
gene
profil
defin
second
ovarian
cancer
use
gener
icamp
gene
predict
valu
gene
ovarian
cancer
would
valid
util
gene
discoveri
approach
control
clinic
predict
valu
gene
also
examin
colon
cancer
determin
direct
dysregul
gene
ovarian
cancer
mine
publish
dataset
one
addit
dataset
cancer
genom
atla
tcga
tabl
collect
contain
normal
cancer
sampl
base
number
dataset
show
dysregul
direct
gene
label
elev
unchang
repress
ovarian
cancer
figur
gene
determin
elev
least
dataset
show
upregul
none
dataset
show
downregul
least
dataset
show
upregul
one
dataset
show
downregul
invers
appli
repress
gene
base
upregul
gene
also
elev
ovarian
cancer
repress
could
determin
among
downregul
gene
also
repress
ovarian
cancer
unchang
elev
undetermin
figur
thu
least
icamp
gene
concordantli
dysregul
ovarian
cancer
colon
ovarian
cancer
dataset
oncomin
well
tcga
colon
cancer
dataset
analyz
clinic
signific
express
level
individu
icamp
gene
number
gene
individu
show
signific
correl
clinic
variabl
colon
cancer
tumor
stage
lymph
node
statu
metastasi
patholog
grade
tabl
select
icamp
gene
consist
elev
repress
cancer
clinic
signific
background
inform
current
find
ednra
upregul
colon
cancer
higher
level
confer
wors
surviv
colon
ovarian
cancer
elev
multipl
type
carcinoma
elev
higher
stage
ovarian
cancer
predict
wors
overal
surviv
colon
cancer
correl
wors
diseas
surviv
upregul
sever
cancer
type
correl
poor
prognosi
ovarian
headneck
colon
cancer
poorli
studi
context
cancer
elev
gastric
pancreat
oral
breast
colon
lung
cancer
mrna
andor
ihc
tnc
elev
multipl
cancer
induc
focal
adhes
overexpress
confer
poorer
surviv
colon
cancer
induc
stabil
ecm
promot
cell
migrat
elev
mrna
peripher
blood
colon
cancer
patient
upregul
metastat
ovarian
cancer
elev
higher
stage
predict
wors
surviv
ovarian
colon
cancer
downregul
mrna
level
cancer
protein
level
cancer
type
glycoprotein
secret
antigen
present
cell
endotheli
cell
fibroblast
respons
inflammatori
stimuli
lower
express
predict
better
surviv
colon
cancer
lower
express
grade
compar
grade
ovarian
cancer
inhibitor
urokinasetyp
plasminogen
activ
upa
downregul
advancedstag
ovarian
cancer
lower
express
confer
wors
surviv
ovarian
cancer
higher
patient
metastat
diseas
secret
ovarian
cancer
cell
respons
hypoxia
mediat
treg
recruit
higher
express
predict
wors
surviv
ovarian
cancer
increas
ovarian
cancer
nodal
metastasi
higher
level
predict
wors
overal
recurrencefre
surviv
consist
repress
cancer
includ
colon
breast
prostat
gastric
pancreat
cancer
lower
express
colon
cancer
predict
wors
surviv
duke
stage
figur
ovarian
cancer
upregul
gene
increas
advanc
stage
higher
patholog
grade
tnc
figur
downregul
icamp
gene
advanc
stage
confer
higher
express
gene
cfd
lower
express
other
clu
pigr
figur
next
determin
icamp
gene
express
level
predict
surviv
base
raw
microarray
data
colon
cancer
ovarian
cancer
gene
show
differ
express
level
survivor
nonsurvivor
one
three
andor
five
year
test
kaplanmei
analysi
figur
colon
cancer
better
overal
surviv
predict
higher
level
lower
level
lifr
lox
tnc
figur
dysregul
express
mani
icamp
gene
also
signific
predict
valu
cancer
recurr
figur
stage
iiic
ovarian
cancer
improv
overal
surviv
associ
higher
mrna
level
mif
pigr
lower
level
ednrb
lox
mal
figur
dysegul
mani
gene
also
predict
recurrencefre
surviv
figur
interestingli
lower
express
number
gene
lox
ednra
predict
better
prognosi
ovarian
colon
cancer
hand
elev
predict
better
prognosi
diseas
figur
determin
prognost
valu
icamp
gene
group
inflammatori
gene
integr
score
igi
devis
ovarian
cancer
figur
igi
includ
gene
independ
show
signific
predict
kaplanmei
analysi
score
take
consider
number
gene
within
patient
fall
high
risk
group
well
risk
gene
confer
robust
igi
valid
use
independ
ovarian
cancer
tcga
dataset
base
cutoff
valu
predetermin
initi
train
dataset
stage
iiic
patient
tcga
dataset
categor
either
high
low
risk
gene
gene
tcga
patient
show
poor
prognosi
rel
risk
rr
predetermin
train
dataset
gene
ad
patient
igi
score
tcga
patient
eventu
distribut
differ
igi
score
base
express
level
igi
gene
found
igi
inde
predict
overal
surviv
rr
p
figur
next
focus
colon
adenocarcinoma
headneck
squamou
cell
carcinoma
sinc
overexpress
report
two
cancer
type
nuclearcytoplasm
protein
involv
import
select
cytoplasm
protein
nucleu
bind
nuclear
local
sequenc
nl
cargo
protein
karyopherin
whole
protein
complex
transloc
across
nuclear
envelop
nuclear
pore
complex
npc
among
client
interferoncinduc
transcript
factor
involv
host
immun
respons
examin
express
immunohistrochemistri
use
inhous
tumor
microarray
contain
primari
colon
cancer
specimen
lymph
node
metastas
correspond
adjac
normal
tissu
patient
variou
diseas
stage
found
drastic
increas
express
primari
lymph
node
metastat
colon
tumor
compar
adjac
normal
tissu
figur
express
also
correl
tumor
stage
percentag
posit
cell
increas
figur
given
patient
n
n
categori
found
signific
differ
express
p
differ
also
signific
combin
stage
p
figur
importantli
patient
intens
score
display
wors
overal
surviv
intens
rel
risk
p
figur
similar
colon
cancer
oral
laryng
squamou
cell
carcinoma
display
elev
level
compar
independ
mouth
larynx
normal
tissu
figur
although
show
correl
diseas
stage
higher
grade
posit
cell
grade
posit
cell
carcinoma
compar
grade
p
vs
p
vs
figur
tumor
necrosi
factor
alphainduc
protein
secret
glycoprotein
express
epitheli
cell
leukocyt
normal
inflammatori
condit
antiinflammatori
function
well
establish
differ
inflammatori
condit
osteoarthr
detect
serum
sampl
patient
autoimmun
disord
recent
transcript
profil
blood
colorect
patient
normal
control
qrtpcr
identifi
biomark
colorect
cancer
studi
show
mrna
elev
peripher
blood
cell
colorect
cancer
patient
investig
protein
level
colon
cancer
cell
adjac
normal
epithelium
immunohistochem
stain
colon
cancer
specimen
adjac
normal
tissu
reveal
increas
express
cancer
per
cell
basi
well
increas
frequenc
cell
figur
b
c
protein
level
predict
overal
patient
surviv
data
shown
diseas
recurr
found
trend
toward
wors
recurrencefre
surviv
highli
express
patient
figur
without
reach
statist
signific
rr
p
studi
design
conceptu
experiment
address
novel
hypothesi
cancer
irrespect
etiolog
harbor
share
icamp
evad
immun
surveil
highjack
host
immun
promot
oncoinflammatori
growth
metastasi
unbias
comprehens
datamin
strategi
undertaken
address
hypothesi
mine
common
molecular
express
pattern
larg
number
patient
mani
independ
studi
ensur
consist
find
express
select
gene
confirm
tissu
microarray
although
biolog
signific
find
await
studi
clear
icamp
exist
also
show
signific
clinic
relev
core
icamp
gene
set
reproduc
mani
wellestablish
gene
aberrantli
express
cancer
tissu
vcan
also
uncov
number
new
consist
dysregul
gene
studi
context
anticanc
immun
tabl
exist
icamp
highlight
import
oncoinflamm
one
common
driver
oncogenesi
consist
dysregul
gene
across
cancer
differ
histolog
origin
suggest
similar
set
rule
cancer
follow
order
sabotag
host
immun
respons
engag
growth
invas
remark
icamp
gene
potenti
har
biomark
cancer
aggress
found
strike
predict
gene
diseas
recurr
patient
surviv
number
cancer
fact
molecul
show
consist
aberr
express
prognost
signific
also
suggest
could
potenti
therapeut
target
multipl
cancer
datamin
help
identifi
biomark
potenti
therapeut
target
also
uncov
underli
biolog
human
cancer
exampl
molecular
profil
colon
cancer
reveal
higher
level
cell
home
adhes
molecul
confer
favor
prognosi
studi
icamp
gene
set
enrich
gene
posit
regul
lymphocyt
apoptosi
could
defens
mechan
cancer
cell
decreas
pressur
antitumor
immun
cxc
chemokin
also
enrich
among
overexpress
gene
chemokin
report
play
differ
role
rang
recruit
inflammatori
cell
aid
cancer
invas
dampen
posit
signal
antitumor
immun
downregul
gene
mostli
enrich
immun
effector
molecul
granzym
mal
figur
fact
confer
activ
antitumor
immun
cell
nk
cell
shown
shut
esophag
cancer
moreov
ligand
receptor
downregul
colorect
cancer
provid
mechan
evad
immunesurveil
similarli
granzym
part
cytotox
cell
eosinophil
arsen
tumoricid
activ
mal
first
describ
myelin
lymphocyt
later
report
function
apic
transport
epitheli
cell
thu
disrupt
could
lead
disorgan
polar
protein
downregul
multipl
type
cancer
includ
breast
head
neck
cancer
concept
icamp
analog
pathogenassoci
molecular
pattern
pamp
postul
two
decad
ago
importantli
updownregul
gene
contribut
invas
cancer
studi
tumor
microenviron
consist
complex
interact
among
cancer
stromal
endotheli
immun
cell
given
chang
gene
express
could
activ
process
initi
cancer
cell
eventu
promot
invas
altern
reaction
cell
immun
system
best
illustr
upregul
gene
whose
elev
predict
better
prognosi
downregul
gene
whose
repress
correl
longer
surviv
among
gene
drew
attent
increas
express
cancer
type
mrna
protein
level
limit
express
normal
epithelia
embryon
antigen
shown
express
mous
embryon
stem
cell
normal
human
testi
emerg
varieti
epitheli
nonepitheli
cancer
despit
except
correl
gene
cancer
behavior
across
multipl
cancer
type
function
shape
tumor
behavior
remain
unclear
one
studi
show
promot
invas
phenotyp
human
breast
cancer
cell
vitro
mechan
underli
observ
investig
cellfre
system
report
interact
transcript
factor
involv
maintain
pluripot
selfrenew
embryon
stem
cell
could
express
lead
signific
activ
cancer
cell
produc
oncogen
inflammatori
mediat
possibl
particularli
sinc
seem
gener
nuclear
import
select
transport
key
immunolog
import
transcript
factor
rais
strong
possibl
underli
immunolog
properti
thu
potenti
dual
role
regul
inflamm
well
stem
cell
suggest
could
serv
critic
link
chronic
inflamm
oncogenesi
specul
warrant
studi
sinc
icamp
repres
list
multipl
gene
product
integr
score
index
shall
expect
predict
clinic
behavior
cancer
inde
proven
case
colon
ovarian
cancer
predict
valu
icamp
biomark
await
investig
prospect
studi
much
like
mamaprinth
oncotyp
dxh
optim
person
medic
practic
given
inflammatori
function
icamp
gene
integr
score
could
prove
effect
identifi
high
risk
patient
would
benefit
immunotherapi
regard
signific
effort
alreadi
undertaken
implement
immun
score
stage
cancer
conjunct
tumor
lymph
node
infiltr
n
distal
metastasi
paramet
figur
methodolog
follow
identifi
inflammatori
cancerassoci
molecular
pattern
icamp
tabl
geo
dataset
summari
geo
dataset
differenti
express
gene
identifi
affymetrix
human
genom
plu
platform
use
dataset
pdf
tabl
immunerel
gene
correspond
mrna
ratio
cancer
normal
shade
gene
present
figur
gene
fold
chang
fc
cancer
type
addit
gene
whose
fc
valu
slightli
less
cancer
type
pdf
tabl
protein
express
icamp
gene
protein
express
chang
interpret
human
protein
atla
immunohistochem
stain
upregul
downregul
gene
show
mrna
differenti
express
fold
chang
cancer
type
q
elev
q
repress
chang
na
avail
pdf
